Focus on Clinical Trial Transparency and Lay Person Summary
To contribute with evidence to the debate on the publication of clinical studies, Maxer chose to share its experiences, involving as witnesses the customers with whom is currently working in the convention Focus on Clinical Trials Transparency and Lay Person Summary that will take place in Milan on November 24.
Besides proposing a general framework of the Clinical Trial Transparency, the meeting will deepen the procedures concerning the anonymization, the commercially confidential information, and the imminent production of layperson summary.
Through the voices of its customers and consultants, Maxer intends to propose to pharmaceutical companies a contribution of expertise committed to addressing this new step in the process of dissemination of knowledge to the scientific community and the public.
